FBLN1 and Myocardial fibrosis: This hypothesis that fibulin-1 reflects asymptomatic myocardial fibrosis that is not accompanied by LV hypertrophy and/or reduced ejection fraction, give rise to the possibility that fibulin-1 may add prognostic information to the current echocardiographic follow-up in these patients.